FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.160
-0.060 (-4.92%)
Apr 28, 2025, 9:44 AM EDT - Market open
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $44.38 million as of April 28, 2025. Its market cap has decreased by -88.19% in one year.
Market Cap
44.38M
Enterprise Value
43.25M
1-Year Change
-88.19%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $44.38M, a decrease of -95.31%. That is a compound annual growth rate of -91.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 46.68M | -33.48% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |